<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40958906</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD.</ArticleTitle><Pagination><StartPage>1623136</StartPage><MedlinePgn>1623136</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1623136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2025.1623136</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">This study aimed to investigate the ameliorative effect of dietary fiber on hepatic fibrosis in T2DM combined with MASLD and to seek the appropriate dose of DF for this population.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="UNASSIGNED">This study was a randomized, controlled, open clinical trial. Patients with T2DM and MASLD were recruited from January 2024 to March 2024 in our hospital using the Interactive Web Response System (IWRS) in a 1:1:1 ratio randomly divided into 3 groups. The control patients received traditional diabetes education. Based on health education, the intervention group took DF supplements (Shanghai Jiuben Technology Co., Ltd.) daily for 12 weeks. Each packet of the supplement is 50 grams and contains approximately 12 grams of dietary fiber (DF). The intervention group was randomly assigned to two different groups. One group received 24 grams of fiber, which was obtained by consuming two packets, each containing 12 grams of fiber. The other group received 12 grams of fiber by consuming one packet.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Both interventions showed a more significant decrease in HbA1c levels than the control group, but only the difference between the control and 24g intervention groups was statistically significant(-0.6 &#xb1; 0.5 <i>vs</i> -1.6 &#xb1; 0.6, P&lt;.001). The 24g intervention group showed a substantial decrease in FPG compared to the control group and the 12g intervention both at week 8 and week 12 (p &lt; 0.05). Both intervention groups experienced significant reductions in FIB-4 levels (p&lt;0.05), with the intervention with 24g group showing the most significant decrease.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our study demonstrated that dietary fiber improved liver fibrosis and glycemic control, with a more pronounced effect in patients from the 24g Intervention group. However, this group had no statistically significant change in BMI, possibly due to higher caloric intake from additional fiber.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Chen, Liu, Huang, Meng, Fang, Han, Zou, Gu, Hu, Ma, Han and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xi-Shuang</ForeName><Initials>XS</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hui-Zhen</ForeName><Initials>HZ</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Jing-Xian</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Hui-Ming</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qian-Wen</ForeName><Initials>QW</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yue-Xia</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Sui-Jun</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Yangpu District Shidong Hospital of Shanghai, Endocrinology and Metabolism, Shanghai,&#xa0;China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004043">Dietary Fiber</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004043" MajorTopicYN="Y">Dietary Fiber</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="Y">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002523" MajorTopicYN="Y">Edible Grain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">fibrosis-4 index (FIB-4)</Keyword><Keyword MajorTopicYN="N">liver fibrosis</Keyword><Keyword MajorTopicYN="N">nutritional intervention</Keyword><Keyword MajorTopicYN="N">transient elastography</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>17</Day><Hour>4</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40958906</ArticleId><ArticleId IdType="pmc">PMC12434759</ArticleId><ArticleId IdType="doi">10.3389/fendo.2025.1623136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): A state-of-the-art review. J Obes Metab Syndr. (2023) 32:197&#x2013;213. doi:&#xa0; 10.7570/jomes23052, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7570/jomes23052</ArticleId><ArticleId IdType="pmc">PMC10583766</ArticleId><ArticleId IdType="pubmed">37700494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sergi CM. NAFLD (MASLD)/NASH (MASH): does it bother to label at all? A comprehensive narrative review. Int J Mol Sci. (2024) 25. doi:&#xa0; 10.3390/ijms25158462, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25158462</ArticleId><ArticleId IdType="pmc">PMC11313354</ArticleId><ArticleId IdType="pubmed">39126031</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanazi YA, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Bahaa MM, et al. Role of autophagy in type 2 diabetes mellitus: the metabolic clash. J Cell Mol Med. (2024) 28:e70240. doi:&#xa0; 10.1111/jcmm.70240, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.70240</ArticleId><ArticleId IdType="pmc">PMC11629865</ArticleId><ArticleId IdType="pubmed">39656379</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Liu L, Cao YY, Gao X, Targher G, Byrne CD, et al. MAFLD as part of systemic metabolic dysregulation. Hepatol Int. (2024) 18:834&#x2013;47. doi:&#xa0; 10.1007/s12072-024-10660-y, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12072-024-10660-y</ArticleId><ArticleId IdType="pubmed">38594474</ArticleId></ArticleIdList></Reference><Reference><Citation>McGlinchey AJ, Govaere O, Geng D, Ratziu V, Allison M, Bousier J, et al. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease. JHEP Rep. (2022) 4:100477. doi:&#xa0; 10.1016/j.jhepr.2022.100477, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhepr.2022.100477</ArticleId><ArticleId IdType="pmc">PMC9006858</ArticleId><ArticleId IdType="pubmed">35434590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Zheng Y, Zheng J, Liang Q, Zhen Q, Cui M, et al. Theabrownin from Fu Brick tea ameliorates high-fat induced insulin resistance, hepatic steatosis, and inflammation in mice by altering the composition and metabolites of gut microbiota. Food Funct. (2024) 15:4421&#x2013;35. doi:&#xa0; 10.1039/D3FO05459D, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3FO05459D</ArticleId><ArticleId IdType="pubmed">38563324</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalobos E, Miguelez-Crespo A, Morgan RA, Ivatt L, Paul M, Simpson JP, et al. ATP-binding cassette family C member 1 constrains metabolic responses to high-fat diet in male mice. J Endocrinol. (2024) 262. doi:&#xa0; 10.1530/JOE-24-0024, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-24-0024</ArticleId><ArticleId IdType="pmc">PMC11301423</ArticleId><ArticleId IdType="pubmed">38829241</ArticleId></ArticleIdList></Reference><Reference><Citation>Martyshina AV, Sirotkina AG, Gosteva IV. Temporal multiscale modeling of biochemical regulatory networks: Calcium-regulated hepatocyte lipid and glucose metabolism. Biosystems. (2024) 240:105227. doi:&#xa0; 10.1016/j.biosystems.2024.105227, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biosystems.2024.105227</ArticleId><ArticleId IdType="pubmed">38718915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo T, Gao L, Yao Z, Shao S, Wang X, Proud CG, et al. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Cell Metab. (2024) 36:947&#x2013;68. doi:&#xa0; 10.1016/j.cmet.2024.04.006, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2024.04.006</ArticleId><ArticleId IdType="pubmed">38718757</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao W, Fan M, Qian H, Li Y, Wang L. Quinoa polyphenol extract alleviates non-alcoholic fatty liver disease via inhibiting lipid accumulation, inflammation and oxidative stress. Nutrients. (2024) 16. doi:&#xa0; 10.3390/nu16142276, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16142276</ArticleId><ArticleId IdType="pmc">PMC11279623</ArticleId><ArticleId IdType="pubmed">39064719</ArticleId></ArticleIdList></Reference><Reference><Citation>Naimi F, Lafl&#xe8;che CRD, Battista MC, Carpentier AC, Baillargeon JP. Antilipolytic Insulin Sensitivity Indices Measured during an Oral Glucose Challenge: Associations with Insulin-Glucose Clamp and Central Adiposity in Women without Diabetes. Endocrinol Metab (Seoul). (2025). doi:&#xa0; 10.3803/EnM.2024.2129, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2024.2129</ArticleId><ArticleId IdType="pmc">PMC12409164</ArticleId><ArticleId IdType="pubmed">40101329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Wang M, Wang Z, Qiu J, Wang Y, Li J, et al. Polysaccharides from hawthorn fruit alleviate high-fat diet-induced NAFLD in mice by improving gut microbiota dysbiosis and hepatic metabolic disorder. Phytomedicine. (2025) 139:156458. doi:&#xa0; 10.1016/j.phymed.2025.156458, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2025.156458</ArticleId><ArticleId IdType="pubmed">39919328</ArticleId></ArticleIdList></Reference><Reference><Citation>Varra FN, Varras M, Varra VK, Theodosis-Nobelos P. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation&#x2212;mediating treatment options (Review). Mol Med Rep. (2024) 29. doi:&#xa0; 10.3892/mmr.2024.13219, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2024.13219</ArticleId><ArticleId IdType="pmc">PMC11025031</ArticleId><ArticleId IdType="pubmed">38606791</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutari C, DeMarsilis A, Mantzoros CS. Obesity and diabetes. Diabetes Res Clin Pract. (2023) 202:110773. doi:&#xa0; 10.1016/j.diabres.2023.110773, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2023.110773</ArticleId><ArticleId IdType="pubmed">37356727</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang C, Duanmu Y, Zhang C, Zhao W, Wang L, et al. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol. (2018) 91:20170587. doi:&#xa0; 10.1259/bjr.20170587, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20170587</ArticleId><ArticleId IdType="pmc">PMC6475942</ArticleId><ArticleId IdType="pubmed">30028193</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JW, Kim HY, Yu JH, Kim MN, Chon YE, An JH, et al. Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis. Clin Mol Hepatol. (2024) 30:S147&#x2013;s158. doi:&#xa0; 10.3350/cmh.2024.0330, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3350/cmh.2024.0330</ArticleId><ArticleId IdType="pmc">PMC11493353</ArticleId><ArticleId IdType="pubmed">39048521</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh JH, Ahn SB, Cho S, Nah EH, Yoon EL, Jun DW. Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort. J Hepatol. (2024) 81:772&#x2013;80. doi:&#xa0; 10.1016/j.jhep.2024.05.042, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2024.05.042</ArticleId><ArticleId IdType="pubmed">38879175</ArticleId></ArticleIdList></Reference><Reference><Citation>EASL-EASD-EASO . EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. (2024) 81:492&#x2013;542. doi:&#xa0; 10.1016/j.jhep.2024.04.031, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2024.04.031</ArticleId><ArticleId IdType="pubmed">38851997</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. (2011) 43:617&#x2013;49. doi:&#xa0; 10.3109/07853890.2010.518623, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2010.518623</ArticleId><ArticleId IdType="pubmed">21039302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano M, Kuromatsu R, Kawaguchi T. Ultrasonographic assessment of tissue stiffness: recent progress in transient elastography and shear wave elastography in the liver and various organs. Kurume Med J. (2024) 70:1&#x2013;10. doi:&#xa0; 10.2739/kurumemedj.MS7012010, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2739/kurumemedj.MS7012010</ArticleId><ArticleId IdType="pubmed">38763738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi R, Oda T, Nagashima K. Comparison of the diagnostic accuracy of shear wave elastography with transient elastography in adult nonalcoholic fatty liver disease: a systematic review and network meta-analysis of diagnostic test accuracy. Abdom Radiol (NY). (2025) 50:734&#x2013;46. doi:&#xa0; 10.1007/s00261-024-04546-8, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00261-024-04546-8</ArticleId><ArticleId IdType="pmc">PMC11794403</ArticleId><ArticleId IdType="pubmed">39240377</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: Definition and subtypes. Clin Mol Hepatol. (2023) 29:S5&#x2013;s16. doi:&#xa0; 10.3350/cmh.2022.0424, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3350/cmh.2022.0424</ArticleId><ArticleId IdType="pmc">PMC10029964</ArticleId><ArticleId IdType="pubmed">36577427</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol (Lausanne). (2022) 13:1087260. doi:&#xa0; 10.3389/fendo.2022.1087260, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1087260</ArticleId><ArticleId IdType="pmc">PMC9884828</ArticleId><ArticleId IdType="pubmed">36726464</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohouli MH, Bagheri SE, Fatahi S, Rohani P. The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Obes Sci Pract. (2024) 10:e758. doi:&#xa0; 10.1002/osp4.758, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/osp4.758</ArticleId><ArticleId IdType="pmc">PMC11047132</ArticleId><ArticleId IdType="pubmed">38682153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H, Liu Y. Management of non-alcoholic fatty liver disease: Lifestyle changes. World J Gastroenterol. (2024) 30:2829&#x2013;33. doi:&#xa0; 10.3748/wjg.v30.i22.2829, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v30.i22.2829</ArticleId><ArticleId IdType="pmc">PMC11212717</ArticleId><ArticleId IdType="pubmed">38947294</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakilpour A, Amini-Salehi E, Soltani Moghadam A, Keivanlou MH, Letafatkar N, Habibi A, et al. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review. Nutr Diabetes. (2024) 14:25. doi:&#xa0; 10.1038/s41387-024-00281-7, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-024-00281-7</ArticleId><ArticleId IdType="pmc">PMC11087547</ArticleId><ArticleId IdType="pubmed">38729941</ArticleId></ArticleIdList></Reference><Reference><Citation>Deehan EC, Mocanu V, Madsen KL. Effects of dietary fibre on metabolic health and obesity. Nat Rev Gastroenterol Hepatol. (2024) 21:301&#x2013;18. doi:&#xa0; 10.1038/s41575-023-00891-z, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-023-00891-z</ArticleId><ArticleId IdType="pubmed">38326443</ArticleId></ArticleIdList></Reference><Reference><Citation>Niero M, Bartoli G, De Colle P, Scarcella M, Zanetti M. Impact of dietary fiber on inflammation and insulin resistance in older patients: A narrative review. Nutrients. (2023) 15. doi:&#xa0; 10.3390/nu15102365, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15102365</ArticleId><ArticleId IdType="pmc">PMC10220584</ArticleId><ArticleId IdType="pubmed">37242248</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk M, Maciejewska D, Ryterska K, Czerwi&#x144;ka-Rogowska M, Jamio&#x142;-Milc D, Skonieczna-&#x17b;ydecka K, et al. Gut permeability might be improved by dietary fiber in individuals with nonalcoholic fatty liver disease (NAFLD) undergoing weight reduction. Nutrients. (2018) 10. doi:&#xa0; 10.3390/nu10111793, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111793</ArticleId><ArticleId IdType="pmc">PMC6266494</ArticleId><ArticleId IdType="pubmed">30453660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitzke D, Czermainski J, Rosa C, Coghetto C, Fernandes SA, Carteri RB. Increasing dietary fiber intake for type 2 diabetes mellitus management: A systematic review. World J Diabetes. (2024) 15:1001&#x2013;10. doi:&#xa0; 10.4239/wjd.v15.i5.1001, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v15.i5.1001</ArticleId><ArticleId IdType="pmc">PMC11099360</ArticleId><ArticleId IdType="pubmed">38766430</ArticleId></ArticleIdList></Reference><Reference><Citation>Saboo B, Misra A, Kalra S, Mohan V, Aravind SR, Joshi S, et al. Role and importance of high fiber in diabetes management in India. Diabetes Metab Syndr. (2022) 16:102480. doi:&#xa0; 10.1016/j.dsx.2022.102480, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2022.102480</ArticleId><ArticleId IdType="pubmed">35594690</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee . 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care. (2024) 47:S20&#x2013;s42. doi:&#xa0; 10.2337/dc24-S002, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc24-S002</ArticleId><ArticleId IdType="pmc">PMC10725812</ArticleId><ArticleId IdType="pubmed">38078589</ArticleId></ArticleIdList></Reference><Reference><Citation>EASL-EASD-EASO . EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary. Diabetologia. (2024) 67:2375&#x2013;92. doi:&#xa0; 10.1007/s00125-024-06196-3, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-024-06196-3</ArticleId><ArticleId IdType="pmc">PMC11519095</ArticleId><ArticleId IdType="pubmed">38869512</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, et al. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American association for the study of liver diseases (AASLD). Endocr Pract. (2022) 28:528&#x2013;62. doi:&#xa0; 10.1016/j.eprac.2022.03.010, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.03.010</ArticleId><ArticleId IdType="pubmed">35569886</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A, Feng D, Planinic P, Ebersole JL, Lyons TJ, Alexander JM. Dietary blueberry and soluble fiber supplementation reduces risk of gestational diabetes in women with obesity in a randomized controlled trial. J Nutr. (2021) 151:1128&#x2013;38. doi:&#xa0; 10.1093/jn/nxaa435, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/nxaa435</ArticleId><ArticleId IdType="pmc">PMC8112774</ArticleId><ArticleId IdType="pubmed">33693835</ArticleId></ArticleIdList></Reference><Reference><Citation>Timm M, Offringa LC, Van Klinken BJ, Slavin J. Beyond insoluble dietary fiber: bioactive compounds in plant foods. Nutrients. (2023) 15. doi:&#xa0; 10.3390/nu15194138, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15194138</ArticleId><ArticleId IdType="pmc">PMC10574517</ArticleId><ArticleId IdType="pubmed">37836422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Liu C, Ye Z, Zhou C, Liu M, Zhang Y, et al. Variety and quantity of dietary-insoluble fiber intake from different sources and risk of new-onset diabetes. J Clin Endocrinol Metab. (2022) 108:175&#x2013;83. doi:&#xa0; 10.1210/clinem/dgac526, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac526</ArticleId><ArticleId IdType="pmc">PMC10091492</ArticleId><ArticleId IdType="pubmed">36074905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu K, Yu T, Cao X, Xia H, Wang S, Sun G, et al. Effect of viscous soluble dietary fiber on glucose and lipid metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis on randomized clinical trials. Front Nutr. (2023) 10:1253312. doi:&#xa0; 10.3389/fnut.2023.1253312, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1253312</ArticleId><ArticleId IdType="pmc">PMC10500602</ArticleId><ArticleId IdType="pubmed">37720378</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds AN, Akerman AP, Mann J. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PloS Med. (2020) 17:e1003053. doi:&#xa0; 10.1371/journal.pmed.1003053, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003053</ArticleId><ArticleId IdType="pmc">PMC7059907</ArticleId><ArticleId IdType="pubmed">32142510</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciejewska-Markiewicz D, Drozd A, Palma J, Ryterska K, Hawry&#x142;kowicz V, Za&#x142;&#x119;ska P, et al. Fatty acids and eicosanoids change during high-fiber diet in NAFLD patients-randomized control trials (RCT). Nutrients. (2022) 14. doi:&#xa0; 10.3390/nu14204310, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14204310</ArticleId><ArticleId IdType="pmc">PMC9608825</ArticleId><ArticleId IdType="pubmed">36296994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. (2018) 359:1151&#x2013;6. doi:&#xa0; 10.1126/science.aao5774, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao5774</ArticleId><ArticleId IdType="pubmed">29590046</ArticleId></ArticleIdList></Reference><Reference><Citation>Francelino Andrade E, Vieira Lobato R, Vasques Ara&#xfa;jo T, Gilberto Zanger&#xf4;nimo M, Vicente Sousa R, Jos&#xe9; Pereira L. Effect of beta-glucans in the control of blood glucose levels of diabetic patients: a systematic review. Nutr Hosp. (2014) 31:170&#x2013;7. doi:&#xa0; 10.3305/nh.2015.31.1.7597, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3305/nh.2015.31.1.7597</ArticleId><ArticleId IdType="pubmed">25561108</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. (2016) 17:510&#x2013;9. doi:&#xa0; 10.1111/obr.12407, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12407</ArticleId><ArticleId IdType="pubmed">27020692</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilalta A, Guti&#xe9;rrez JA, Chaves S, Hern&#xe1;ndez M, Urbina S, Hompesch M. Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH. Endocrinol Diabetes Metab. (2022) 5:e00335. doi:&#xa0; 10.1002/edm2.335, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/edm2.335</ArticleId><ArticleId IdType="pmc">PMC9094496</ArticleId><ArticleId IdType="pubmed">35388643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Q, Ma B, Zhao Y, Zhao L, Zhang Z, Gao H, et al. Soluble dietary fiber significance against obesity in a western China population. J Healthc Eng. (2021) 2021:5754160. doi:&#xa0; 10.1155/2021/5754160, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5754160</ArticleId><ArticleId IdType="pmc">PMC8526253</ArticleId><ArticleId IdType="pubmed">34676062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kromhout D, Bloemberg B, Seidell JC, Nissinen A, Menotti A. Physical activity and dietary fiber determine population body fat levels: the Seven Countries Study. Int J Obes Relat Metab Disord. (2001) 25:301&#x2013;6. doi:&#xa0; 10.1038/sj.ijo.0801568, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ijo.0801568</ArticleId><ArticleId IdType="pubmed">11319625</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Shi Y, Wei D, Ni W, Zhu N, Yan X. Impact of a high dietary fiber cereal meal intervention on body weight, adipose distribution, and cardiovascular risk among individuals with type 2 diabetes. Front Endocrinol (Lausanne). (2023) 14:1283626. doi:&#xa0; 10.3389/fendo.2023.1283626, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1283626</ArticleId><ArticleId IdType="pmc">PMC10642937</ArticleId><ArticleId IdType="pubmed">37964962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins DJ, Kendall CW, Axelsen M, Augustin LS, Vuksan V. Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol. (2000) 11:49&#x2013;56. doi:&#xa0; 10.1097/00041433-200002000-00008, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00041433-200002000-00008</ArticleId><ArticleId IdType="pubmed">10750694</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, Zeng XF, Liu ZN, Zhao QH, Tan YT, Gao J, et al. Diet and liver cancer risk: a narrative review of epidemiological evidence. Br J Nutr. (2020) 124:330&#x2013;40. doi:&#xa0; 10.1017/S0007114520001208, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114520001208</ArticleId><ArticleId IdType="pubmed">32234090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Yang H, Zhang Y, Rao S, Mo Y, Zhang H, et al. Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity. Front Public Health. (2022) 10:1038435. doi:&#xa0; 10.3389/fpubh.2022.1038435, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1038435</ArticleId><ArticleId IdType="pmc">PMC9853063</ArticleId><ArticleId IdType="pubmed">36684870</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Montes de Oca A, Juli&#xe1;n MT, Ramos A, Puig-Domingo M, Alonso N. Microbiota, fiber, and NAFLD: is there any connection? Nutrients. (2020) 12. doi:&#xa0; 10.3390/nu12103100, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12103100</ArticleId><ArticleId IdType="pmc">PMC7600472</ArticleId><ArticleId IdType="pubmed">33053631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Li J, Fu J, Shao L, Yang L, Shi J. Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds. Chin Med J (Engl). (2023) 136:1390&#x2013;400. doi:&#xa0; 10.1097/CM9.0000000000002711, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000002711</ArticleId><ArticleId IdType="pmc">PMC10278733</ArticleId><ArticleId IdType="pubmed">37200041</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai HJ, Hung WC, Hung WW, Lee YJ, Chen YC, Lee CY, et al. Circulating short-chain fatty acids and non-alcoholic fatty liver disease severity in patients with type 2 diabetes mellitus. Nutrients. (2023) 15. doi:&#xa0; 10.3390/nu15071712, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15071712</ArticleId><ArticleId IdType="pmc">PMC10097193</ArticleId><ArticleId IdType="pubmed">37049552</ArticleId></ArticleIdList></Reference><Reference><Citation>Caetano-Silva ME, Rund L, Hutchinson NT, Woods JA, Steelman AJ, Johnson RW. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci Rep. (2023) 13:2819. doi:&#xa0; 10.1038/s41598-022-27086-x, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-27086-x</ArticleId><ArticleId IdType="pmc">PMC9935636</ArticleId><ArticleId IdType="pubmed">36797287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ, Zhang W. Role of dietary nutrients in the modulation of gut microbiota: A narrative review. Nutrients. (2020) 12. doi:&#xa0; 10.3390/nu12020381, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020381</ArticleId><ArticleId IdType="pmc">PMC7071260</ArticleId><ArticleId IdType="pubmed">32023943</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Pan X, Luo J, Xiao X, Li J, Bestman PL, et al. Association of inflammatory cytokines with non-alcoholic fatty liver disease. Front Immunol. (2022) 13:880298. doi:&#xa0; 10.3389/fimmu.2022.880298, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.880298</ArticleId><ArticleId IdType="pmc">PMC9122097</ArticleId><ArticleId IdType="pubmed">35603224</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill SK, Rossi M, Bajka B, Whelan K. Dietary fibre in gastrointestinal health and disease. Nat Rev Gastroenterol Hepatol. (2021) 18:101&#x2013;16. doi:&#xa0; 10.1038/s41575-020-00375-4, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-020-00375-4</ArticleId><ArticleId IdType="pubmed">33208922</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva AM, J&#xfa;dice PB, Carra&#xe7;a EV, King N, Teixeira PJ, Sardinha LB. What is the effect of diet and/or exercise interventions on behavioural compensation in non-exercise physical activity and related energy expenditure of free-living adults? A systematic review. Br J Nutr. (2018) 119:1327&#x2013;45. doi:&#xa0; 10.1017/S000711451800096X, PMID: , PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S000711451800096X</ArticleId><ArticleId IdType="pubmed">29845903</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>